Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Bradley K Wacker"'
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 30, Iss , Pp 558-572 (2023)
Coronary artery venous bypass grafts typically fail because of atherosclerosis driven by lipid and macrophage accumulation. Therapy for vein-graft atherosclerosis is limited to statin drugs, which are only modestly effective. We hypothesized that tra
Externí odkaz:
https://doaj.org/article/0bb220201f12424e87cc8fd11799d3dc
Autor:
Meena Sethuraman, Nagadhara Dronadula, Lianxiang Bi, Bradley K. Wacker, Ethan Knight, Pieter De Bleser, David A. Dichek
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Transduction of endothelial cells (EC) with a vector that expresses apolipoprotein A-I (APOAI) reduces atherosclerosis in arteries of fat-fed rabbits. However, the effects on atherosclerosis are partial and might be enhanced if APOAI express
Externí odkaz:
https://doaj.org/article/2ad6ece108b24aa594c3f46484bd534d
Autor:
Lianxiang Bi, Bradley K. Wacker, Emma Bueren, Ervin Ham, Nagadhara Dronadula, David A. Dichek
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 7, Iss C, Pp 96-111 (2017)
Coronary artery bypass vein grafts are a mainstay of therapy for human atherosclerosis. Unfortunately, the long-term patency of vein grafts is limited by accelerated atherosclerosis. Gene therapy, directed at the vein graft wall, is a promising appro
Externí odkaz:
https://doaj.org/article/08277880b0d9448b9216520e24c2ffaa
Autor:
Bradley K. Wacker, Lianxiang Bi, Li Liu, Mary G. Sorci-Thomas, Philip Ng, Donna J. Palmer, Chongren Tang, David A. Dichek
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868:159301
Autor:
Lianxiang Bi, David A. Dichek, Alexis Stamatikos, Meena Sethuraman, Bradley K. Wacker, Kaushik Komandur
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Supplemental Digital Content is available in the text.
Objective: Efficient gene transfer to the vascular wall via intravenous vector injection would be useful for experimental vascular biology and gene therapy. Initial studies of lentiviral vec
Objective: Efficient gene transfer to the vascular wall via intravenous vector injection would be useful for experimental vascular biology and gene therapy. Initial studies of lentiviral vec
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 42
Background: Obstructed arteries are often treated by surgical implantation of venous bypass grafts. Vein grafts can fail for many reasons, including thrombosis, atherosclerosis, or anastomotic stenoses (narrowings where the grafts connect to the arte
Autor:
Bradley K Wacker, Lianxiang Bi, Mary Sorci-Thomas, Philip Ng, Donna Palmer, Chongren Tang, David Dichek
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 42
Introduction: Gene therapy using a helper-dependent adenovirus (HDAd) to express rabbit apolipoprotein (apo) AI in carotids of fat-fed rabbits reduces atherosclerosis. We hypothesize that transgenic apoAI promotes reverse cholesterol transport from t
Autor:
Lianxiang Bi, Bradley K. Wacker, Ethan Knight, Chongren Tang, Lucia Vojtech, Alexis Stamatikos, David A. Dichek
Publikováno v:
Hum Gene Ther
Atherosclerosis is a disease of large- and medium-sized arteries that is caused by cholesterol accumulation in arterial intimal cells, including macrophages and smooth muscle cells (SMC). Cholesterol accumulation in these cells can be prevented or re
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 38:206-217
Objective— Gene therapy that expresses apo A-I (apolipoprotein A-I) from vascular wall cells has promise for preventing and reversing atherosclerosis. Previously, we reported that transduction of carotid artery endothelial cells with a helper-depen
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37:316-327
Objective— Gene therapy, delivered directly to the blood vessel wall, could potentially prevent atherosclerotic lesion growth and promote atherosclerosis regression. Previously, we reported that a helper-dependent adenoviral (HDAd) vector expressin